XBiotech Inc. Common Stock XBIT
i
Market datapartial · fetched 2026-11-07T08:06:20.396Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-06T21:00:00.464328703Z
FundamentalsAlpha Vantage · unavailable
XBiotech Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 3.12 | 707.1% | 80.4% | |||
| 25Δ | 3.45 | 657.3% | 71.3% | |||
| 30Δ | 3.78 | 607.6% | 62.2% | |||
| 35Δ | 4.11 | 557.9% | 53.1% | |||
| 40Δ | 4.44 | 508.2% | 44.0% | |||
| 45Δ | 4.77 | 458.5% | 34.9% | |||
| 50Δ | 7.26 | 483.7% | 28.6% | |||
| 55Δ | ||||||
| 60Δ | ||||||
| 65Δ | ||||||
| 70Δ | 4.84 | 586.9% | 207.6% | |||
| 75Δ | ||||||
| 80Δ | ||||||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.12
- IV
- 707.1%
- B/E move
- 80.4%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.45
- IV
- 657.3%
- B/E move
- 71.3%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.78
- IV
- 607.6%
- B/E move
- 62.2%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.11
- IV
- 557.9%
- B/E move
- 53.1%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.44
- IV
- 508.2%
- B/E move
- 44.0%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 4.77
- IV
- 458.5%
- B/E move
- 34.9%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 7.26
- IV
- 483.7%
- B/E move
- 28.6%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 4.84
- IV
- 586.9%
- B/E move
- 207.6%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
XENE
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company…
More →XFOR
X4 Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for the treatment of back…
More →XNCR
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed to treat cancer patients…
More →ZBIO
Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based therapies. The company is…
More →ZLAB
Description unavailable
More →ZNTL
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapies for the treatment of various cancers.…
More →